Compare Five Below Inc (FIVE) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Five Below Inc vs Recursion Pharmaceuticals Inc — how do they compare? Five Below Inc trades at $200.15 (market cap $10.67B), while Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.75B). The key difference: Five Below Inc is far larger — about 6.1× Recursion Pharmaceuticals Inc's market cap, and Five Below Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| FIVE | RXRX | |
|---|---|---|
Market Cap | $10.67B | $1.75B |
Sector | Consumer Staples | Health |
52-Week High | $247.71 | $6.79 |
52-Week Low | $131.94 | $2.84 |
Enterprise Value | $11.56B | $1.17B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Five Below Inc
Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics
Read more on FIVE →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
